Latest Articles
Study Finds GLP-1 Agonists Combined with Progestin Reduce Endometrial Cancer Risk by 66% - geneonline.com
Study Finds GLP-1 Agonists Combined with Progestin Reduce Endometrial Cancer Risk by 66% geneonline.com
Published: Feb. 16, 2026, 5:37 a.m.
GLP-1 Combination Reduced Endometrial Cancer Risk by 66%, Study Finds - Pharmacy Times
GLP-1 Combination Reduced Endometrial Cancer Risk by 66%, Study Finds Pharmacy Times
Published: Feb. 13, 2026, 5:09 p.m.
Genetic risk may rival obesity as a key driver of endometrial cancer - Medical Xpress
Genetic risk may rival obesity as a key driver of endometrial cancer Medical Xpress
Published: Feb. 12, 2026, 8:16 p.m.
How Should Inoperable Endometrial Cancer be Treated? - CancerNetwork
How Should Inoperable Endometrial Cancer be Treated? CancerNetwork
Published: Feb. 12, 2026, 4:05 p.m.
Endometrial immune cell profile at the time of frozen embryo transfer as prognostic indicator of live birth - Frontiers
Endometrial immune cell profile at the time of frozen embryo transfer as prognostic indicator of live birth Frontiers
Published: Feb. 12, 2026, 1:22 p.m.
The Scan by 2 Minute Medicine®: Daily caffeine intake linked to lower dementia risk, AAP sues over federal vaccine schedule overhaul, Catherine O’Hara passes away after short illness, and GLP-1 receptor agonists reduce endometrial cancer risk - 2 Minute Medicine
The Scan by 2 Minute Medicine®: Daily caffeine intake linked to lower dementia risk, AAP sues over federal vaccine schedule overhaul, Catherine O’Hara passes away after short illness, and GLP-1 …
Published: Feb. 11, 2026, 6:31 p.m.
The Intricacy and Importance of Treating Inoperable Endometrial Cancer - CancerNetwork
The Intricacy and Importance of Treating Inoperable Endometrial Cancer CancerNetwork
Published: Feb. 11, 2026, 6:02 p.m.
Research sheds light on key drivers of endometrial cancer - The National Tribune
Research sheds light on key drivers of endometrial cancer The National Tribune
Published: Feb. 11, 2026, 2:10 p.m.
Endometrial Cancer Treatment Market Is Going to Boom |• Merck & Co. • Bristol-Myers Squibb - openPR.com
Endometrial Cancer Treatment Market Is Going to Boom |• Merck & Co. • Bristol-Myers Squibb openPR.com
Published: Feb. 11, 2026, 12:24 p.m.
Dual role of the endometrial microbiome-immune axis: From endometrial | IJWH - Dove Medical Press
Dual role of the endometrial microbiome-immune axis: From endometrial | IJWH Dove Medical Press
Published: Feb. 11, 2026, 9:02 a.m.
Link copied to clipboard!